Hodgkin lymphoma arising in patients with chronic lymphocytic leukemia: outcomes from a large multi-center collaboration
Deborah M. Stephens(University of North Carolina at Chapel Hill), John C. Byrd(University of Cincinnati), Jennifer H. Cooperrider(University of Chicago), Brian T. Hill(Cleveland Clinic), Allison Winter(Cleveland Clinic), Sameer A. Parikh(Mayo Clinic), John M. Pagel(University of Washington), Kerry A. Rogers(The Ohio State University), Danielle M. Brander(Duke University), Erin M. Parry(Broad Institute), Mazyar Shadman(University of Washington), Joanna Rhodes(Roswell Park Comprehensive Cancer Center), Tycel Phillips(Michigan Medicine), Matthew S. Davids(Dana-Farber Cancer Institute), Alexey V. Danilov(City of Hope), Sameh Gaballa(Johns Hopkins Hospital), Kenneth M. Boucher(University of Utah), Anthony R. Mato(Memorial Sloan Kettering Cancer Center), Elizabeth Kander(The Ohio State University), Martha Glenn(Huntsman Cancer Institute), Sonali M. Smith(University of Chicago)
Cited by 36
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|9.9k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.9k
iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL
|Blood|2018|1.7k
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2014|1.7k